Pfizer Total Non-Operating Income/Expense 2010-2025 | PFE
Pfizer total non-operating income/expense for the twelve months ending March 31, 2025 was $-4.661B, a 643.38% increase year-over-year.
- Pfizer annual total non-operating income/expense for 2024 was $-4.388B, a 1876.58% increase from 2023.
- Pfizer annual total non-operating income/expense for 2023 was $-0.222B, a 79.1% decline from 2022.
- Pfizer annual total non-operating income/expense for 2022 was $-1.062B, a 121.77% decline from 2021.